Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU
Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025
Seeking Alpha / 2 hours from now 1 Views
Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU
Comments